Find out about Dr. Landau’s innovative research in this video
NYGC Core Faculty Member Dan Landau, MD, PhD, who holds a joint appointment as Assistant Professor of Medicine in the Division of Hematology and Medical Oncology and the Department of Physiology and Biophysics at Weill Cornell Medicine, has been awarded the 2018 Pershing Square Sohn Prize for Young Investigators in Cancer Research
He is one of seven winners of the coveted award, which is given to early career investigators. The Pershing Square Foundation supports young investigators who demonstrate creativity, passion, and an ability to think unconventionally while exploring new territory in research to discover cures for cancer.
Dr. Landau’s research focuses on precision customization of anti-cancer therapy to prevent tumor evolution to treatment resistance – an area that remains a major, underexplored, emerging theme across the field of oncology. Using unique tools that he recently developed, Dr. Landau’s laboratory will define both genetic and non-genetic changes at the level of a single cancer cell that enable leukemia cells to diversify and evolve to overcome therapy.
As part of the Pershing Foundation’s effort to further New York City’s growth as a biomedical research hub, each awardee of the prize receives $200,000 per year for up to three years.
